Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.82 USD | +2.49% | -6.82% | -12.42% |
05-09 | UBS Adjusts Price Target on REGENXBIO to $39 From $43, Maintains Buy Rating | MT |
05-08 | Transcript : REGENXBIO Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.42% | 761M | |
+5.02% | 109B | |
+11.01% | 105B | |
-0.38% | 22.25B | |
-12.05% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.06% | 16.85B | |
+3.61% | 13.76B | |
+35.95% | 12.46B |
- Stock Market
- Equities
- RGNX Stock
- News REGENXBIO Inc.
- Sector Update: Health Care